TRUP · Trupanion, Inc.

The departure of Max Brodén from Trupanion’s Board of Directors represents a routine governance transition rather than a signal of strategic or operational concern. As stated in the filing, his decision was made for personal reasons and involved no disagreement with the company or fellow directors—reducing governance risk implications. His continued service through the June 10, 2026 Annual Meeting ensures continuity during the transition period. Critically, Trupanion explicitly affirms that this change does not alter the status or trajectory of its strategic partnership with Aflac, a material shareholder and collaborator; Aflac’s ongoing commitment is underscored as both supportive and aligned. While director changes are inherently governance-relevant, the absence of controversy, disclosure of succession planning, or linkage to performance issues limits materiality. The concurrent filing of the 2025 Annual Report (referenced under Item 7.01) provides broader context but contains no earnings or forward-looking disclosures in this 8-K itself—thus no financial or operational implications are introduced here.